Peptide Alarm Therapy (PAT) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Pembrolizumab

Filter by location:

Minneapolis, Minnesota1 trial

Study of PAT in Patients With Solid Tumor Cancers

Masonic Cancer Center at University of Minnesota

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.